Summary
The chemotherapeutic combination of cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) was used to treat 15 children with recurrent central nervous system tumors and seven children with newly diagnosed brainstem tumors. In patients with recurrent tumors, marginal activity was seen in various histologic types. COPP chemotherapy was clearly ineffective in patients with brainstem tumors. Toxicity consisted of mild to moderate myelosuppression and neurotoxicity.
Similar content being viewed by others
References
Young JL, Miller RW: Incidence of malignant tumors in U.S. children. J Pediatr 86:254–258, 1975.
Rosenstock JG, Evans AE, Schut L: Response to vincristine of recurrent brain tumors in children. J Neurosurg 45:135–140,1976.
Kumar ARV, Renaudin J, Wilson CB, Boldrey EB, Enot KJ, Levin VA: Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study. J Neurosurg 40:365–371, 1974.
Walker MD, Hurwitz BS: BCNU (1,3-bis(2-chloroethyl)-l-nitrosourea; NSC-409962) in the treatment of malignant brain tumor- a preliminary report. Cancer Chemother Rep 54:263–271, 1970.
Wilson CB, Boldrey, EB, Enot KJ: 1,3-Bis(2-chloroethyl)-l-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemother Rep 54:273–281, 1970.
Fewer D, Wilson CB, Boldrey, EB, Enot JK: Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors. Cancer Chemother Rep 56:421–427, 1972.
Khan AB, D'Souza BJ, Wharam MD, Champion LAA, Sinks LF, Woo SY, McCullough DC, Leventhal BG: Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 66:2013–2020, 1982.
Stewart DJ, O'Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N: Phase II study of cisplatin in recurrent astrocytomas in adults: A Southwest Oncoloy Group study. J Neuro-oncology 1:145–147, 1983.
Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749–756,1981.
Bloom HJG: Intracranial tumors: Response and resistance to therapeutic endeavors, 1970–1980. Int J Radiation Oncology Biol Phys 8:1083–1113, 1982.
Ertel I, Boesel C, Evans A, Jenkin D, Ortega J, Sposto R, Venes J, Wara W, Leikin S, Hammond D: Adjuvant chemotherapy of high grade astrocytomas in children: Radiation therapy with or without CCNU, vincristine, and prednisone. Proc Am Soc Clin Oncol 3:79, 1984 (Abstract C-309).
Venes JL, McIntosh S, O'Brien RT, Schwartz AD: Chemotherapy as an adjunct in the initial management of cerebellar medulloblastoma: A preliminary report. J Neurosurg 50:721–724,1979.
Allen JC, Helson L, Jereb B: Pre-radiation chemotherapy for newly diagnosed childhood brain tumors: A modified Phase II trial. Cancer 52:2001–2006, 1983.
Frias-Monserrate AE, Van Eys J, Cangir A: Combined chemotherapy in the treatment of recurrent brain tumors. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 17:266, 1976 (Abstract C-120).
Kontras SB, Newton, WA Jr: Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma: Preliminary report. Cancer Chemotherapy Rep 12:39–50, 1961.
Cangir A, Van Eys J, Berry DH, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 4:253–261, 1978.
Cangir A, Ragab AH, Steuber P, Land VJ, Berry DH, Krischer JP: Combination chemotherapy with vincristine (NSC-67574), procarbazine(NSC-77213), prednisone(NSC-10023) with or without nitrogen mustard. (NSC-762) (MOPP vs OPP) in children with recurrent brain tumors. Med Pediatr Oncol 12:1–3, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ettinger, L.J., Sinniah, D., Siegel, S.E. et al. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. J Neuro-Oncol 3, 263–269 (1985). https://doi.org/10.1007/BF00165188
Issue Date:
DOI: https://doi.org/10.1007/BF00165188